Efficacy and Safety of High-dose Interferon Alfa-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma (Study P04083)
Clinical trial NCT00749684 · COMPLETED
Trial details
- NCT number
- NCT00749684
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 1996-12-01
- Primary completion
- 2009-09-01
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.